Prediction of Placental Fetal Growth Restriction in High Risk Population (PoPFGR)

Fetal Growth Retardation Clinical Trial

Official title: Prediction of Placental Fetal Growth Restriction in High Risk Population (PoPFGR)

Status Recruiting

Clinical Trial Summary

This study intends to prospectively enroll high-risk pregnant women to establish a multicenter cohort. By combining maternal basic characteristics, medical history, early pregnancy ultrasound, and biological markers, we aim to construct a joint predictive model for MVM-FGR.

Clinical Trial Description

Clinical guidelines do not recommend clinical screening for MVM-FGR in low-risk populations. Predictive models for FGR are often based on preeclampsia prediction models or Down syndrome serum screening models, which have limited utility. This study aims to establish a multi-center prospective cohort of pregnant women at high risk for FGR. We will collect baseline characteristics of pregnant women, ultrasound measurements of fetal growth, structural scans, maternal-fetal Doppler blood flow, as well as maternal serum and plasma in first and mid-trimester. Serum and plasma biomarker testing will be conducted. We will regularly observe fetal growth data, maternal-fetal complications during pregnancy, and collect delivery information, conditions of the newborn and placental pathology results after birth. By integrating maternal medical history, serum and plasma biomarkers, Doppler ultrasound, and other factors, we will establish a combined predictive model for early and mid-term MVM-FGR. ;

Related Conditions & MeSH terms

• Fetal Growth Retardation

• NCT number: NCT06096805
• Study type: Observational
• Source: Shanghai First Maternity and Infant Hospital
• Contact: Jianping Chen, Master
• Phone: 13916159565
• Email: urchin_chen@163.com
• Status: Recruiting
• Start date: August 10, 2023
• Completion date: December 30, 2025